1 |
Gu G, Ren J, Zhu B, Shi Z, Feng S, Wei Z. Multiple mechanisms of curcumin targeting spinal cord injury. Biomed Pharmacother 2023;159:114224. [PMID: 36641925 DOI: 10.1016/j.biopha.2023.114224] [Reference Citation Analysis]
|
2 |
Shen Y, Cai J. The Importance of Using Exosome-Loaded miRNA for the Treatment of Spinal Cord Injury. Mol Neurobiol 2023;60:447-59. [PMID: 36279099 DOI: 10.1007/s12035-022-03088-8] [Reference Citation Analysis]
|
3 |
Zhang J, Shi W, Qu D, Yu T, Qi C, Fu H. Extracellular vesicle therapy for traumatic central nervous system disorders. Stem Cell Res Ther 2022;13:442. [PMID: 36056445 DOI: 10.1186/s13287-022-03106-5] [Reference Citation Analysis]
|
4 |
Feng Y, Peng Y, Jie J, Yang Y, Yang P. The immune microenvironment and tissue engineering strategies for spinal cord regeneration. Front Cell Neurosci 2022;16:969002. [DOI: 10.3389/fncel.2022.969002] [Reference Citation Analysis]
|
5 |
Guo Y, Gil Z. The Role of Extracellular Vesicles in Cancer-Nerve Crosstalk of the Peripheral Nervous System. Cells 2022;11:1294. [PMID: 35455973 DOI: 10.3390/cells11081294] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
6 |
Ren L, Chen S, Yao D, Yan H. OxLDL-stimulated macrophage exosomes promote proatherogenic vascular smooth muscle cell viability and invasion via delivering miR-186-5p then inactivating SHIP2 mediated PI3K/AKT/mTOR pathway. Mol Immunol 2022;146:27-37. [PMID: 35421738 DOI: 10.1016/j.molimm.2022.02.018] [Reference Citation Analysis]
|